hydroxy-3 (pyrrolyl-1)-2 pyridine | 102064-28-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: hydroxy-3 (pyrrolyl-1)-2 pyridine
• 英文别名: 1-(3-hydroxy-2-pyridyl)pyrrole；2-(1H-pyrrol-1-yl)-3-pyridinol；1-(3-hydroxy-pyridin-2-yl)pyrrole；2-Pyrrol-1-ylpyridin-3-ol
• CAS: 102064-28-8
• 化学式: C₉H₈N₂O
• 分子量: 160.175
• InChiKey: QSOYMKHARYDZGH-UHFFFAOYSA-N

物化性质

• 熔点：
  198 °C(Solv: acetonitrile (75-05-8))
• 沸点：
  396.3±27.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  hydroxy-3 (pyrrolyl-1)-2 pyridine 在 sodium hydroxide 、 五氯化磷 、 sodium hydride 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 24.0h， 生成 (+/-)-6-(naphth-1-yl)pyrido[3,2-b]pyrrolo[1,2-d][1,4]oxazepin-7(6H)-one
  参考文献：
  名称：

  Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target

  摘要：

  We have recently developed five novel pyrrolo-1,5-benzoxazepines as proapoptotic agents. Their JNK-dependent induction of apoptosis in tumor cells suggested their potential as novel anticancer agents. The core structure of the apoptotic agent 6 was investigated, and the SARs were expanded with the design and synthesis of several analogues. To define the apoptotic mechanism of the new compounds and the localization of their drug target, two analogues of 6 were designed and synthesized to delineate events leading to JNK activation. The cell-penetrating compound 16 induced apoptosis in tumor cells, while its nonpenetrating analogue, 17, was incapable of inducing apoptosis or activating JNK. Plasma membrane permeabilization of tumor cells resulted in 17-induced JNK activation, suggesting that the pyrrolo-1,5-benzoxazepine molecular target is intracellular. Interestingly, compound 6 displayed cytotoxic activity against a panel of human tumor cell lines but demonstrated negligible toxicity in vivo with no effect on the animals' hematology parameters.

  DOI：

  10.1021/jm049402y
• 作为产物：
  描述：

  2,5-二甲氧基四氢呋喃 、 2-氨基-3-羟基吡啶 在 溶剂黄146 作用下， 反应 0.5h， 以4.7 g的产率得到hydroxy-3 (pyrrolyl-1)-2 pyridine
  参考文献：
  名称：

  吡咯并苯并氮杂庚酮衍生物作为非核苷HIV-1 RT抑制剂：进一步的结构活性关系研究和鉴定具有抗病毒活性的更有效的广谱HIV-1 RT抑制剂。

  摘要：

  吡咯并苯并恶唑酮（PBO）衍生物代表一类新型的人类免疫缺陷病毒1型（HIV-1）非核苷逆转录酶（RT）抑制剂（NNRT），其原型为（+/-）-6-乙基-6-苯基吡咯烷酮[2] ，1-d] [1,5]苯并x庚因-7（6H）-一（6）。基于RT三维结构的对接研究促进了6的新型衍生物和类似物的合成和生物学评估，这些衍生物和类似物的特征是在C-6处有间位取代的苯基或2-噻吩基环，并有吡啶体系代替了苯环生成吡咯并吡咯并恶唑酮（PPO）。与前导6和奈韦拉平相比，几种合成的化合物（PBO 13a-d和PPO 13i-k）对野生型RT和含有单个氨基酸取代L100I，K103N，V106A， Y181I和Y188L。进一步评估了最有效的抑制剂对淋巴细胞和单核巨噬细胞的体外抗病毒活性，对一系列细胞系的细胞毒性以及与AZT的潜在协同抗病毒活性。在13b，13c和13i上进行的药代动力学研究表明，这些化合物在大脑

  DOI：

  10.1021/jm990150o

文献信息

• Synthesis of New Molecular Probes for Investigation of Steroid Biosynthesis Induced by Selective Interaction with Peripheral Type Benzodiazepine Receptors (PBR)
  作者：Giuseppe Campiani、Anna Ramunno、Isabella Fiorini、Vito Nacci、Elena Morelli、Ettore Novellino、Mara Goegan、Tiziana Mennini、Stephen Sullivan、Daniela M. Zisterer、Clive D. Williams

  DOI：10.1021/jm020849l

  日期：2002.9.1

  synthesized and tested novel pyridopyrrolo- and pyrrolobenzoxazepine derivatives, as novel and selective peripheral type benzodiazepine receptor (PBR) ligands, and their ability to modulate steroid biosynthesis has been investigated. A subset of new ligands bind the PBR (rat brain and testis) with picomolar affinity, representing the most potent ligands that have been identified to date, and elicited effects

  在本研究中，我们已经合成并测试了新颖的吡咯并吡咯并吡咯并吡咯并a庚因衍生物，作为新颖的和选择性的外周型苯并二氮杂receptor受体（PBR）配体，并研究了它们调节类固醇生物合成的能力。一组新的配体以皮摩尔亲和力结合了PBR（大鼠的大脑和睾丸），代表了迄今已鉴定出的最有效的配体，并引起了对MA10 Leydig细胞中类固醇生成的内源性速率的作用，具有与PK11195相似的效力和作用。 。使用几种在C-7处不同取代的化合物作为分子标准，以探测受体结合位点中亲脂性口袋L4的空间尺寸。
• [EN] HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS<br/>[FR] AMIDES DE CHROMÈNE HÉTÉROCYCLIQUE-PIPÉRIDINE SPIROCYCLIQUE UTILES COMME MODULATEURS DES CANAUX IONIQUES
  申请人：VERTEX PHARMA

  公开号：WO2011140425A1

  公开（公告）日：2011-11-10

  The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及杂环色烯-螺环哌啶酰胺，用作离子通道的抑制剂。本发明还提供了包含本发明化合物的药用可接受组合物，以及使用这些组合物治疗各种疾病的方法。
• [EN] BENZOXAZINES AS MODULATORS OF ION CHANNELS<br/>[FR] BENZOXAZINES COMME MODULATEURS DES CANAUX IONIQUES
  申请人：VERTEX PHARMA

  公开号：WO2013067248A1

  公开（公告）日：2013-05-10

  The invention relates to benzoxazines useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及可用作离子通道抑制剂的苯并噁嗪。本发明还提供了包含本发明化合物的药用可接受组合物，以及使用这些组合物治疗各种疾病的方法。
• Palladium(<scp>ii</scp>)-catalyzed aerobic oxidative O–H/C–H isocyanide insertion: facile access to pyrrolo[2,1-<i>c</i>][1,4]benzoxazine derivatives
  作者：Liangliang Luo、Xiao-Pan Chen、Zhao-Feng Li、Yuan Zhou、You-Cai Xiao、Fen-Er Chen

  DOI：10.1039/d1ob00393c

  日期：——

  Palladium-catalyzed aerobic oxidative cyclizations of substituted 2-(1H-pyrrol-1-yl)phenols with isocyanides via an O–H/C–H insertion cascade have been developed. This strategy provides facile access to pyrrolo[2,1-c][1,4]benzoxazine derivatives in good to excellent yields under an O2 atmosphere. The notable features of this protocol include its mild reaction conditions, atom-economy, and broad functional

  钯催化的取代 2-(1 H -pyrrol-1-yl) 苯酚与异氰化物通过O-H/C-H 插入级联反应进行了有氧氧化环化。该策略提供了在 O 2气氛下以良好至优异产率轻松获得吡咯并[2,1- c ][1,4]苯并恶嗪衍生物的途径。该协议的显着特点包括其温和的反应条件、原子经济性和广泛的官能团耐受性。
• Apoptosis-inducing compounds
  申请人：The Universita'di Siena

  公开号：US06806267B1

  公开（公告）日：2004-10-19

  The present invention relates to pyrrolobenzoxazepines, pyrrolobenzthiazepines and related compounds having the ability to induce apoptosis, to pharmaceutical compositions comprising these compounds and to their use as anti-tumour agents.

  本发明涉及能够诱导细胞凋亡的吡咯苯并噁唑环烯和吡咯苯并噻唑环烯以及相关化合物，涉及包含这些化合物的药物组合物，以及它们作为抗肿瘤剂的用途。